SCHEMBL20825820

SCHEMBL20825820

c1ccc2c(c1)ccc1c3ccccc3n(-c3ccc4cc(-n5c6ccccc6c6ccc7ccccc7c65)ccc4c3)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPRT1 P00492 3/20 0.39
ALDH1A1 P00352 4/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP2A6 P11509 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
RAB9A P51151 2/20 0.36
PMM2 O15305 1/20 0.36
MPI P34949 1/20 0.36
PHOSPHO1 Q8TCT1 1/20 0.36
HIF1A Q16665 1/20 0.36
CYP1B1 Q16678 1/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13828805 0.98 KDM4E (0.41) KDM4EATML3MBTL1HPRT1ALDH1A1
SCHEMBL10027551 0.91 KDM4E (0.44) KDM4EATML3MBTL1ALDH1A1CYP2A6
SCHEMBL24374076 0.91 CYP2A6 (0.44) KDM4EATML3MBTL1ALDH1A1CYP2A6
SCHEMBL17989806 0.91 KDM4E (0.47) KDM4EATML3MBTL1ALDH1A1TSHR
SCHEMBL15073675 0.90 KDM4E (0.53) KDM4EATML3MBTL1ALDH1A1TSHR
SCHEMBL21448355 0.89 KDM4E (0.47) KDM4EATML3MBTL1HPRT1ALDH1A1
SCHEMBL26809537 0.89 ALDH1A1 (0.41) KDM4EATML3MBTL1HPRT1ALDH1A1
SCHEMBL21709015 0.89 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1RAB9A
SCHEMBL19769472 0.88 KDM4E (0.50) KDM4EATML3MBTL1ALDH1A1RAB9A
SCHEMBL27451928 0.88 KDM4E (0.47) KDM4EATML3MBTL1HPRT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793074-B2 Organic compound and photoelectric conversion element CANON KABUSHIKI KAISHA (JP) 2023-10-17 US disclosed
US-11793074-B2 Organic compound and photoelectric conversion element CANON KABUSHIKI KAISHA (JP) 2023-10-17 US disclosed
US-20210057653-A1 ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT CANON KK (JP) 2021-02-25 US disclosed
US-10868260-B2 Organic compound and photoelectric conversion element CANON KABUSHIKI KAISHA (JP) 2020-12-15 US disclosed
US-20190088885-A1 ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT CANON KABUSHIKI KAISHA (JP) 2019-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793074-B2 Organic compound and photoelectric conversion element CRY1, CYP1A1, CCNE2 KDM4E 1730/4885ATM 2983/4885L3MBTL1 1860/4885
US-20210057653-A1 ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT CRY1, CYP1A1, CCNE2 KDM4E 1730/4885ATM 2983/4885L3MBTL1 1860/4885
US-10868260-B2 Organic compound and photoelectric conversion element CRY1, CYP1A1, CCNE2 KDM4E 1730/4885ATM 2983/4885L3MBTL1 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.